Research Report on Kidney Transplant Market for United States, Mexico & Canada Regions

The improvement in technology, surgical techniques and immunosuppressive drugs, Kidney transplantation has became the preferred treatment for chronic kidney disease for many people. A transplant may offer the best chance of returning to a more normal life. Kidney transplantation has increasingly become a pivotal intervention for thousands of patients suffering from fatal end stage kidney disease (ESRD).

North America is one of the biggest kidney transplant market in the world. The overall number of Kidney Transplant done in North America (United States, Mexico and Canada) was more than 20 Thousand in 2014. United States is the leader in kidney transplant market in North America. Canada has the least number of kidney transplant done in comparison to United States and Mexico. Despite its high medical cost today United States Kidney Transplant Market is a Billion US$ industry.

“Kidney Transplant Market, Numbers & Forecast for United States, Mexico & Canada” explores a comprehensive assessment of the fast–evolving, high growth Kidney Transplant Market. This 53 page report with 33 Figures & 1 Table provides the number of kidney transplant, as well as market and market shares of Kidney Transplant Market. The report entails major kidney transplant (Immunosuppressant) drug sales analysis. This report also covers drivers and challenges of North America (United States, Mexico and Canada) market.

Purchase a copy of this report at http://www.marketreportsonline.com/contacts/purchase.php?name=400060 .

All the 3 Countries studied in the report are as follows

• United States

• Canada

• Mexico

All the 6 Kidney Transplant Immunosuppressant) drugs studied in the report are as follows

• CellCept (MycophenolateMofetil)

• Prograf (Tacrolimus)

• Rapamune (Sirolimus)

• Myfortic (Mycophenolic Acid)

• Neoral / Sandimmune (Cyclosporine)

• Zortress / Certican (Everolimus)

View Complete Report @ http://www.marketreportsonline.com/400060.html .

Table of Contents...